| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 85 |
| 1 | METHOTREXATE SODIUM | 23 |
| 2 | BEVACIZUMAB | 22 |
| 3 | METHOTREXATE | 19 |
| 4 | FOLIC ACID | 17 |
| 5 | PREDNISONE | 15 |
| 6 | PACLITAXEL | 13 |
| 7 | VEDOLIZUMAB | 13 |
| 8 | AZATHIOPRINE | 11 |
| 9 | CARBOPLATIN | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 1 | SORBITOL | 1 | 0.0017 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 3 | DANAZOL | 2 | 0.0007 |
| 4 | TIROFIBAN | 2 | 0.0007 |
| 5 | PLERIXAFOR | 1 | 0.0007 |
| 6 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 7 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| 8 | SULINDAC | 1 | 0.0004 |
| 9 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 3 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 35 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 22 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 4 | Vitamin C [EPC] | 20 |
| 5 | Vitamin D [EPC] | 20 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 19 |
| 8 | Vitamin B12 [EPC] | 18 |
| 9 | Opioid Agonist [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 3 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 4 | GLP-2 Analog [EPC] | 3 | 0.0002 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 6 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 7 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 9 | 0.0002 |
| 8 | Integrin Receptor Antagonist [EPC] | 13 | 0.0001 |
| 9 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |